Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Cash Flow Reinvestment Rate
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow Reinvestment Rate of 0.85x as of December 2025, reinvesting CN¥2.03 Billion (capex CN¥1.28 Billion plus investments CN¥753.03 Million) from operating cash flow of CN¥2.40 Billion. Check 600196 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Explore Shanghai Fosun Pharmaceutical Group Co L strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Shanghai Fosun Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Shanghai Fosun Pharmaceutical Group Co L (600196) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.12x | CN¥6.75 Billion | CN¥6.01 Billion | CN¥4.45 Billion | ▼ -0.5% |
| 2024 | 1.13x | CN¥5.06 Billion | CN¥4.48 Billion | CN¥4.41 Billion | ▼ -46.1% |
| 2023 | 2.10x | CN¥9.16 Billion | CN¥4.36 Billion | CN¥5.34 Billion | ▼ -0.7% |
| 2022 | 2.11x | CN¥8.91 Billion | CN¥4.22 Billion | CN¥5.89 Billion | ▲ +60.9% |
| 2021 | 1.31x | CN¥5.19 Billion | CN¥3.95 Billion | CN¥4.97 Billion | ▼ -34.1% |
| 2020 | 1.99x | CN¥5.14 Billion | CN¥2.58 Billion | CN¥4.44 Billion | ▼ -20.8% |
| 2019 | 2.52x | CN¥8.11 Billion | CN¥3.22 Billion | CN¥3.96 Billion | ▲ +42.6% |
| 2018 | 1.76x | CN¥5.21 Billion | CN¥2.95 Billion | CN¥3.17 Billion | ▲ +34.4% |
| 2017 | 1.31x | CN¥3.39 Billion | CN¥2.58 Billion | CN¥2.17 Billion | ▼ -36.6% |
| 2016 | 2.07x | CN¥4.37 Billion | CN¥2.11 Billion | CN¥1.92 Billion | ▲ +41.5% |
| 2015 | 1.46x | CN¥2.37 Billion | CN¥1.62 Billion | CN¥1.24 Billion | ▲ +56.9% |
| 2014 | 0.93x | CN¥1.12 Billion | CN¥1.20 Billion | CN¥1.12 Billion | ▼ -9.3% |
| 2013 | 1.03x | CN¥1.04 Billion | CN¥1.01 Billion | CN¥1.04 Billion | ▼ -41.0% |
| 2012 | 1.74x | CN¥1.16 Billion | CN¥665.52 Million | CN¥1.16 Billion | ▼ -30.7% |
| 2011 | 2.52x | CN¥796.83 Million | CN¥316.65 Million | CN¥796.83 Million | ▲ +50.9% |
| 2010 | 1.67x | CN¥339.17 Million | CN¥203.36 Million | CN¥339.17 Million | ▲ +25.5% |
| 2009 | 1.33x | CN¥348.07 Million | CN¥261.87 Million | CN¥348.07 Million | ▲ +47.1% |
| 2008 | 0.90x | CN¥210.63 Million | CN¥233.04 Million | CN¥210.63 Million | ▼ -43.3% |
| 2007 | 1.59x | CN¥209.71 Million | CN¥131.48 Million | CN¥209.71 Million | ▲ +10.6% |
| 2006 | 1.44x | CN¥266.61 Million | CN¥184.91 Million | CN¥266.61 Million | ▲ +22.0% |
| 2005 | 1.18x | CN¥222.60 Million | CN¥188.35 Million | CN¥222.60 Million | ▲ +18.2% |
| 2004 | 1.00x | CN¥205.02 Million | CN¥205.10 Million | CN¥205.02 Million | ▼ -43.2% |
| 2003 | 1.76x | CN¥264.05 Million | CN¥150.14 Million | CN¥264.05 Million | ▲ +29.2% |
| 2002 | 1.36x | CN¥139.52 Million | CN¥102.47 Million | CN¥139.52 Million | ▼ -34.4% |
| 2001 | 2.08x | CN¥141.51 Million | CN¥68.15 Million | CN¥141.51 Million | ▲ +127.0% |
| 2000 | 0.91x | CN¥126.63 Million | CN¥138.43 Million | CN¥126.63 Million | ▼ -55.2% |
| 1999 | 2.04x | CN¥77.99 Million | CN¥38.20 Million | CN¥77.99 Million | ▲ +160.1% |
| 1998 | 0.79x | CN¥52.25 Million | CN¥66.55 Million | CN¥52.25 Million | — |